We describe the cloning and initial characterization of a novel cDNA from human embryonal carcinoma (EC) cells. This cDNA, which we named human growth dierentiation factor 3 (hGDF3), encodes the homologue of mouse GDF3, a TGFb superfamily member belonging to the Growth/Dierentiation Factors. We have analysed the expression of hGDF3 in human embryonal carcinoma cell lines and in primary testicular germ cell tumours of adolescents and adults (TGCTs). Expression of hGDF3 in human EC cell lines is stem cell-speci®c, is downregulated upon RA-mediated dierentiation and is increased upon culture of the cells in the presence of activin A. In TGCTs, hGDF3 expression is low in seminomas, while expression in non-seminomas is readily detectable and appears to be associated with the EC and yolk sac components in the tumours. We have also mapped the hGDF3 locus to the short arm of human chromosome 12, a region consistently overrepresented in human testicular germ cell tumours. Thus, hGDF3 represents an embryonal carcinoma stem cell-associated marker both in vitro and in vivo.
Introduction
The Transforming Growth Factor b (TGFb) superfamily comprises a growing number of structurally related polypeptide growth factors (Kingsley, 1994a,b; Hogan, 1996) , isolated from both vertebrates (e.g. Vg-1, Vgr-1, the Activins, Bone Morphogenetic Proteins, Mullerain Inhibiting Substance, TGFbs) and invertebrates (e.g. DPP, 60A). Many of these factors have been shown to modulate various biological processes ranging from the control of cellular proliferation and dierentiation to morphogenesis (Kingsley, 1994a,b; Hogan, 1996) . Activins and Bone Morphogenetic Proteins (BMPs) have received considerable attention for their activity in mesoderm inducing and bone and cartilage inducing assays, respectively (Kingsley, 1994a,b) . In mouse P19 embryonal carcinoma (EC) cells, activin can inhibit dierentiation as elicited by retinoic acid (RA), indicating a potential role in the maintenance of the stem cell phenotype (van den Eijnden-van Raaij et al., 1991) . Because of this ®nding we set out to investigate the possible action of activin on cultured human EC cells, which serve as a model for both the stem cells of human testicular nonseminomatous germ cell tumours and early human developmental processes. Activin is thought to play an important role in gonadal development and function (de Jong et al., 1994) , and expression of activin subunits and its receptors in human testicular germ cell tumours of adolescents and adults (TGCTs; van Schaik et al., 1997) suggests a potential role for this growth factor in aspects of germ cell tumour development. Like their murine counterparts, human EC cells resemble the multipotential stem cells of early mammalian embryos, and as in vitro cultures respond to various treatments by undergoing dierentiation (reviewed in Andrews et al., 1987) . We are employing two human EC cell lines, TERA-2 (T2cl13) and NTERA-2 (NT2D1), as model systems to study the action of activin in modulating developmental decisions occurring during early human development and during the development of TGCTs in man. Both cell lines express the transcripts and protein for the receptors required to respond to activin (de Jong et al., 1993; van Schaik, personal communication; de Winter, personal communication) . Further, we and others have found that activin can elicit a biological response in human EC cells (Caricasole et al., manuscript in preparation; Andrews et al., 1994) . The study of activin-regulated gene expression in a cell culture system representing an oncodevelopmental model provides an opportunity to identify genes whose activity is involved in mediating activin signalling during development and neoplasia. From such analysis we isolated a novel human cDNA encoding a member of the TGFb superfamily, related by sequence to mouse GDF3 (mGDF3; McPherron and Lee, 1993 ; also known as Vgr-2: Jones et al., 1992) . Southern blotting of mouse and human genomic DNA as well as considerable amino acid and nucleotide sequence relatedness indicate that it represents the human homologue of GDF3. Expression of this novel human cDNA in human EC cell lines, in selected fetal and adult human tissues, and in human TGCTs is described. We also report the regulation of hGDF3 expression by activin A and RA in human EC cell lines. Further, we have mapped hGDF3 to the short arm of chromosome 12, a region consistently overrepresented in TGCTs (review: de Jong et al., 1990) .
Results
Isolation of dierentially expressed cDNA fragments and cloning of the human GDF3 cDNA
In order to isolate genes whose expression is modulated by activin A or retinoic acid in human EC cells, monolayer cultures of TERA-2 and NTERA-2 were treated with activin A (10 ng/ml), retinoic acid (5 mM) or a combination of the two agents for 30 min. Following RNA isolation and reverse transcription, fragments of cDNAs enriched in treated samples but not in control samples were isolated as described in the methods section. A number of dierentially displayed PCR products were detected upon agarose gel electrophoresis (data not shown) in samples derived from cells treated with retinoic acid, retinoic acid and activin A, and activin A alone. The dierentially displayed PCR products representing candidate activin-regulated cDNAs were cloned and sequenced. Translation of one of these products revealed signi®cant homology to the published mouse GDF3 precursor protein (amino acid positions 53 ± 229).
In order to obtain the complete cDNA sequence for the novel human cDNA, RACE ± PCR cDNA cloning was carried out as described in the experimental procedures. 5' RACE ± PCR yielded a single product of ca. 270 bp, partially overlapping the original clone, which upon DNA sequencing was shown to represent a fragment of hGDF3 cDNA containing an in frame translational initiation codon shortly preceded by two successive, in frame stop codons. We deduced this DNA fragment represented the 5' end of the hGDF3 cDNA. 3' RACE ± PCR yielded a product of 650 bp, again partially overlapping the original clone, which represented the 3' end of the cDNA, encoding the mature portion of the protein. This region contained a high degree of homology at the level of both DNA and amino acid sequence to the published mGDF3 sequence. Conceptual translation of the compiled cDNA sequences (Figure 1 ) revealed an open reading frame (ORF) totalling 313 amino acids (aa), with a theorectical molecular weight of 35 kDa. At the 5' end of the cDNA the ®rst methionine codon of the ORF is shortly preceded by two successive in frame stop codons (Figure 1) . A hydrophobic NH 2 -terminal region may represent a signal sequence for protein secretion. As for mGDF3, the conserved cysteine residue thought to be important for dimer formation is missing in hGDF3 (Figure 2 ; McPherron and Lee, 1993) . The characterized hGDF3 cDNA encodes a protein signi®cantly smaller than its mouse counterpart, owing to a shorter precursor region and the absence of two amino acids (positions 128 and 248 in the mouse protein; Figure 2 ), again in the precursor region. These dierences may be due to the presence of alternatively spliced forms of the hGDF3 transcript, or may represent species-speci®c dierences in the structure of the protein. 5' RACE ± PCR experiments failed to detect other transcript variants in human EC cells, suggesting the presence of a single transcript species in these cells. Notably, a high degree of conservation is shared between hGDF3 and mGDF3 in the mature part of the peptide (Figure 2 ). Genomic Southern hybridization analysis of hGDF3 and mapping to the short arm of human chromosome 12
Although alignment of hGDF3 and mGDF3 sequences strongly suggested the novel human cDNA represented the homologue of mGDF3, we sought further evidence for this by carrying out Southern blotting analysis on human (T2cl13 cell) genomic and mouse (P19 cell) genomic DNA employing either an hGDF3 or a mGDF3 probe (Figure 3 ). We employed a fragment of hGDF3 comprising sequences between bp 60 and bp 585, 5' of the mature part of the peptide, as a probe in this analysis (see Figure 1 ). We isolated a comparable mGDF3 probe by PCR from mouse P19 EC cell cDNA (comprising sequences between bp 138 and bp 835 in the published sequence). The human probe cross hybridized to mouse genomic DNA, with a band pattern consistent with the published structure of the mGDF3 genomic locus. The blot was stripped and reprobed with mGDF sequences. Again, hybridization to mouse genomic DNA revealed a pattern consistent with the structure of the published mGDF3 genomic locus. Cross hybridization of the mGDF3 probe to human genomic DNA revealed an almost identical banding pattern to that observed employing a hGDF3 probe (Figure 3 ), indicating that hGDF3 represents the human homologue of mGDF3. We next investigated the chromosomal localisation of hGDF3. Polymerase chain reaction (PCR) with hGDF3-speci®c primers on a mouse hybrid cell line containing only human 12p material (Zhang et al., 1989) demonstrated that the gene is located on the short arm of chromosome 12 (not shown). Further con®rmation was obtained by probing blots carrying a panel of monochromosomal hybrids with hGDF3 sequences (not shown). Subsequently, a more detailed mapping was performed ( Figure 4 ) using a series of hamster-human radiation hybrids containing dierent fragments of the short arm of chromosome 12 (Sinke et al., 1992) . Eight hybrids were studied, encompassing the complete 12p. Five were found to be negative (designated in the original manuscript as 6b, 22c, 23b, 28b, and 23.1) and three positive (designated as 8b, 10.1 and 13.1). The only region consistently present in all positive and absent in all negative hybrids was 12p13.1. Therefore it was concluded that hGDF3 maps to the short arm of chromosome 12, most probably to band 13.1. This is consistent with the mapping of mGDF3 to a region of mouse chromosome 6 which is syntenic with human 12p (Jones et al., 1992) . 
Expression of GDF3 in human EC and mouse ES and EC cell lines
The pattern of expression of hGDF3 in a number of EC cell lines was analysed by Northern blotting and RNase protection. Expression was readily observed in all human EC cell lines tested. Multipotent lines (e.g. NT2D1, NCCIT, GCT-63a and GCT-27X1, this latter being a feeder-dependent line) as well as nullipotent EC lines (e.g. Germa-I, Germa-II, GCT-27C4 and 2102 EP) expressed hGDF3 transcripts. Upon prolonged (6 days) RA exposure of T2cl13 and NT2D1 cells hGDF3 transcripts become undetectable (Figures 5 and 6 ). Comparable results were also observed for the multipotent NCCIT and GCT-27X1 cell lines, while in the nullipotent 2102 EP cell line no signi®cant eects of RA treatment on hGDF3 expression were observed (not shown). Dierences with regards to hGDF3 expression were observed between two yolk sac tumour-derived lines, GCT-44 (parietal yolk sac carcinoma, showing no detectable levels of hGDF3) and GCT-72 (visceral yolk sac carcinoma, hGDF3 expression present, Figure 6 ). No detectable expression was observed in S2 cells, a cell line with characteristics of seminoma (Keitz et al., 1994) .
Given the strong expression of hGDF3 in human EC cells and its downregulation upon RA treatment, we were interested in determining whether these aspects of GDF3 expression might be conserved in mouse EC and embryonic stem (ES) cell lines. Northern blot analysis of mGDF3 expression was carried out on RNA samples isolated from mouse ES-5 ES cells and their dierentiated derivatives ( Figure  8) , with material from mouse F9 EC cells as control (e.g. see Jones et al., 1992) . Mouse GDF3 expression is detectable in ES stem cells. Dierentiation of mouse ES cells by RA results in an upregulation of mGDF3 transcripts (day 3 of treatment), with the signal decreasing to basal levels by day 5 of treatment ( Figure 7) . Dierentiation of mouse ES cells by withdrawal of LIF also results in an upregulation of mGDF3 expression (day 3 of treatment). However, this expression is maintained at later stages of dierentiation (day 5 of treatment, Figure 7 ). Thus although dierential regulation of GDF3 in human EC cells parallels the situation observed in mouse EC lines (this study, Jones et al., 1992) , dierentiation of an ES line by two dierent means (LIF withdrawal or RA treatment) results in dierent eects on GDF3 expression.
Modulation of hGDF3 expression by retinoic acid and activin A in human EC cells
The eects of RA and/or activin A (ACT) on the expression of hGDF3 in human EC cells were investigated. Following treatment of T2cl13 or NT2D1 cells with various agents for 24 h, total RNA was isolated and hGDF3 expression addressed by RNase protection (Figure 8 ). Activin can signi®cantly increase steady state levels of hGDF3 transcripts in both T2cl13 and NT2D1 cells. Instead, only marginal eects of RA on hGDF3 expression is seen after 24 h of exposure, suggesting that the downregulation of hGDF3 expression by RA (see Figure 5 ) is not a rapid cellular response in human EC cell lines. This is consistent with results reported for mGDF3 in mouse F9 EC cells (Jones et al., 1992) . These results implicate RA and activin signalling in the mechanisms (transcriptional and/or post-transcriptional) controlling the expression of hGDF3 in human EC cells. (Pera et al., 1987 Damjanov et al., 1993) . GCT-48, -27C4, 2102 EP, Germa-I and Germa-II represent nullipotent EC cell lines (Pera et al., 1988 Prof H Walt, personal communication) . GCT-44 is a parietal yolk sac carcinoma cell line, while GCT-72 represent a visceral yolk sac carcinoma cell line (Pera et al., 1988) . S represents the S2 cell line, with characteristics of seminoma (Keitz et al., 1994) 10 µM RA: -
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1.4 kb GAPDH Figure 5 Northern blot analysis of hGDF3 expression in human EC cell lines and their dierentiated derivatives. Cell lines were T2cl13 (T2), Germa-I (G1), Germa-II (G2), PA-1 (PA), and NT2D1 (NT). RA indicates treatment with retinoic acid for 6 days. Probing with a GAPDH cDNA sequence provides a loading control (Figure 9 ). The highest expression is found in EC and YS, and in other NS bearing a large EC component, while low or absence of hGDF3 expression in NS was invariably associated with dierentiated tumours (e.g. IT and MT). In situ hybridization analyses on TGCT paran embedded tissue sections con®rmed the expression of hGDF3 in EC ( Figure 10 ) and YS components (not shown). Teratoma, trophoblastic, giant cells, stroma and normal parenchyma adjacent to the tumour were negative while also seminoma, CIS and normal testis lacked GDF3 expression (not shown). In a nonseminomatous tumour with overall characteristics of IT, the EC cells (stem cells) present expressed GDF3 while the dierentiating IT elements were negative for GDF3 ( Figure 10 ).
Expression of hGDF3 in human fetal and adult tissues
In order to begin an investigation on the distribution of hGDF3 transcripts during human development we carried out Northern blotting hybridization on RNA from selected human fetal and adult tissues employing a commercially available blot. We were unable to detect signi®cant expression of hGDF3 in all analysed fetal (kidney, liver, heart and brain) and adult tissues (heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas; data not shown). Probing with a GAPDH sequence con®rmed the quality of the blot. We therefore conclude that hGDF3 transcripts are not expressed at detectable levels in the analysed human tissues.
Discussion
We have identi®ed a novel cDNA from human EC cells whose expression is stem cell speci®c both in cells in culture and in tumours in vivo. This cDNA encodes the human homologue of mouse GDF3, a TGFb superfamily member whose biological function is still unknown. In the adult mouse, mGDF3 transcripts have been reported in only a few tissues including thymus, spleen and bone marrow, suggesting a potential role in lymphopoiesis and/or hematopoiesis (McPherron and Lee, 1993) . Other TGFb-related factors have been shown to be modulators of functions in these tissues. For instance, activin is expressed in bone marrow and spleen in the mouse and is a strong inducer of erythroid dierentiation (Shiozaki et al., 1992) . Given the activin inducibility of hGDF3 expression, it will be of interest to determine if activin eects in the hematopoietic system can be mediated by this factor. In this respect we note that we found no evidence of hGDF3 expression in human K562 cells or in their dierentiated erythropoietic cell derivatives resulting upon activin treatment (data not shown). In order to compare hGDF3 expression in vivo with the expression of its mouse counterpart, we analysed expression of hGDF3 in a panel of human fetal and adult tissues which included many of the mouse tissues analysed for GDF3 expression (McPherron and Lee, 1993) . We found no evidence of hGDF3 transcripts in all available tissues. Although RNA samples of spleen, bone marrow and thymus (these tissues showed expression of GDF3 in the adult mouse; McPherron and Lee, 1993) were not available to us, all tissues reported to lack detectable GDF3 expression in the mouse are also negative in the human. Thus hGDF3 is not expressed at detectable levels in a ubiquitous fashion, suggesting temporally and/or spatially restricted expression patterns.
Aside from a possible role in the regulatory aspects of the adult lymphatic and erythroid systems, GDF3 may also have a role during embryonic development. Jones et al. (1992) reported expression of mGDF3 in developing bone and cartilage in mid-gestational embryos. Further, these authors found mGDF3 expression in murine F9 EC stem cells, with transcript levels decreasing following RA treatment. We expanded these observations to include a mouse ES cell line, which is representative of the totipotent cells of pre-implantation mouse embryos, as well as human EC cells. Stem cellspeci®c expression in mouse and human EC and mouse ES cells is suggestive of a role during preimplantation development, while later expression in developing bone and cartilage implies a role in skeletal organogenesis. We note, however, that dierentiation of mouse ES cells by LIF withdrawal does not lead to downregulation of GDF3 transcript levels, as is the case for mouse ES and EC cells and human EC cells dierentiated by RA treatment. Dierentiation of mouse ES cells by LIF withdrawal results in a more complex spectrum of dierentiation than that elicited by RA (Mummery et al., 1990) . Our observation suggests expression of mGDF3 in at least some dierentiated derivatives resulting from dierentiation of ES cells as a consequence of LIF withdrawal. Interestingly, expression of hGDF3 is observed in a human visceral YS cell line (GCT-72), but not in a parietal yolk sac cell line (GCT-44), suggesting that hGDF3 expression can occur in some human EC-derived dierentiated derivatives and drawing a parallel with the situation observed with mouse ES cells. In the absence of studies aimed at de®ning the biological activity and function of GDF3 we can however only speculate as to the signi®cance of these expression patterns.
We sought to determine the generality of stem-cell speci®c expression of hGDF3 by Northern blot analysis of a panel of human EC cell lines and found transcript levels were readily detectable in the stem cell population and declined following differentiation by retinoic acid. Transcripts for hGDF3 are detectable in all human EC cell lines tested, independently of their dierentiation capacity and feeder dependence. Interestingly, downregulation of hGDF3 transcript to very low levels is seen only following prolonged exposure to RA of pluripotent EC cell lines (T2cl13, NT2D1 and NCCIT), while treatment of a nullipotent human EC cell line (2102 EP) with RA did not result in a downregulation of hGDF3 expression. Thus, hGDF3 expression in human EC cell lines is associated with the EC stem cell phenotype. The function of stem-cell speci®c expression of hGDF3 is as yet unknown. While RA, which downregulates hGDF3 expression, is an inducer of EC cell dierentiation, activin can induce cell death in T2cl13 cells (Caricasole et al., manuscript in preparation) . This eect of activin is probably not linked to activin-inducible hGDF3 expression, as hGDF3 transcripts are readily detectable in untreated EC cell cultures. Human EC cells are the stem cells of non seminomatous TGCTs, tumours which are thought to arise pre-meiotically from aberrant male germ cell development (Figure 11 ). The varying histology of these malignancies is re¯ective of qualitative and quantitative dierences in the dierentiation state of individual tumours. We investigated expression of hGDF3 in a panel of TGCTs of characterized histology, in order to determine potential correlations between hGDF3 expression and tumour characteristics. As a class, NS displayed relatively higher expression than SE. In NS, hGDF3 was highly expressed in tumours bearing an EC and/or YS component, with no expression being detectable in mature and immature teratoma as analysed by RNase protection assays. These results were con®rmed by in situ analysis. In a tumour with overall characteristics of IT of the adult testis, EC cells (the stem cells of the tumour) can usually be morphologically demonstrated. In this case the EC cells were positive for GDF3 expression while the IT cells were not, illustrating the potential of GDF3 as an EC cell-speci®c marker.
The extracellular signalling molecules aecting the direction and extent of dierentiation in these tumours are presently unde®ned. Factors which in¯uence human EC cell proliferation and differentiation in vitro clearly represent candidate modulators of in vivo tumour progression and dierentiation. Activin A and the BMP7 have already been described as bioactive agents in human EC cells (Andrews et al., 1994; Caricasole et al., in preparation) and may therefore play a role in TGCT development. Any activin-or BMP-inducible secreted factor (such as hGDF3) must also be considered. The localization of the hGDF3 locus to the short arm of chromosome 12 is of interest due to the frequent overrepresentation of 12p sequences in CIS, in TGCTs and in TGCT-derived cell lines, which suggest a causal relationship between TGCT development and potential oncogene(s) on 12p. Overexpression of hGDF3 in TGCTs and TGCT-derived cell lines is not simply a function of polyploidization of certain genomic sequences (12p), as not all TGCTs and derived cell lines display elevated levels of hGDF3 transcripts and GDF3 mRNA levels are readily detectable in karyotypically normal mouse ES cells. Rather, hGDF3 expression appears to be associated with the stem cell phenotype, as evidenced by its sensitivity to RA-induced differentiation.
Our observations point to a strong correlation between the importance of the EC/YS component of the tumour and hGDF3 expression, a ®nding corroborated by the EC cell-speci®c expression of hGDF3 in the tissue culture systems. hGDF3 expression is undetectable in normal human testis (van Schaik, unpublished) , consistent with data gathered in the mouse (McPherron and Lee, 1993) . The inverse correlation between hGDF3 expression and dierentiation in the tumour and the chromosomal localization of hGDF3 to 12p may suggest a function in the establishment and/or maintenance of the tumour stem cell population.
Materials and methods

Tissue culture
T2cl13 and NT2D1 human EC cells were cultured in gelatinised¯asks in a 1 : 1 ratio of Dulbecco's minimal essential medium and Ham's F12 medium, buered with NaCO3 (44 mM) in a humidi®ed incubator (7.5% CO 2 ). The medium was supplemented with 10% fetal calf serum. Retinoic acid was diluted to a ®nal concentration of 5610 75 M from a 100 mM stock in Dimethyl-sulphoxyde (DMSO) immediately prior to addition to the culture medium. Other cell lines were cultured as previously described (Pera et al., 1988 Keitz et al., 1994) . The dierentiation state of human EC cell cultures was monitored morphologically and by immunocytochemical analysis of the stem cell-speci®c antigen SSEA-3 and SSEA-4. Mouse EC and ES cell lines were cultured as previously described (Mummery et al., 1990) . Morphology and SSEA-1 antigen expression were employed as a measure of the dierentiation state of the cultures. Puri®ed, recombinant human activin A was a gift from Dr de Waele, Innogenetics, Ghent, Belgium.
Reverse transcription and PCR ampli®cation of dierentially expressed cDNAs Total RNA isolation was followed by ®rst strand cDNA synthesis using the primer (dT)12C. In order to enrich for dierentially expressed cDNAs, equivalent aliquots of cDNAs from the various treatments (30 min time point) were hybridized in solution to a 100-fold excess of total RNA from the control (untreated) cells in Taq polymerase 16buer for 6 h at 428C. Second strand cDNA synthesis was then carried out on the hybridized cDNA-RNA pools employing individual arbitrary 20-mer oligonucleotides at 378C. To preferentially amplify second strand synthesis cDNA, PCR was carried out employing the oligonucleotide used for second strand synthesis as primer with the following cycling parameters: 968C/30''; 428C/1'; 728C/1' for 35 cycles. Ampli®cation relies on the presence of an anchor provided by the second strand synthesis primer and Figure 11 Schematic diagram representing a model for TGCT development, and the expression of hGDF3 in dierent compartments. PGC: primordial germ cells; CIS: carcinoma in situ of the testis; SE: seminoma; EC: embryonal carcinoma; TE: teratoma, representative of dierentiation into embryonic cell lineages; YS: yolk sac carcinoma and CH: choriocarcinoma (these latter represent dierentiation into extra-embryonic cell lineages). Compartments in which hGDF3 expression was observed are shaded hGDF3 expression in human EC cells and in human germ cell tumours AAD Caricasole et al on priming at another position along the cDNA; this event is facilitated by the relaxed annealing temperature employed in the PCR. As a control, cDNA synthesized from total RNA extracted from untreated cells was employed in a separate substraction involving total RNA from control cells. PCR products were separated on agarose gels, and dierentially displayed DNAs were cloned using the pGEMT cloning kit as per manufacturer instructions.
RACE cDNA cloning
3' Rapid ampli®cation of cDNA ends (RACE) was carried out by reverse transcription of T2cl13 stem cell polyA RNA employing the primer TAATACGACTCACTA-TAGGGGCGGCCGC(T) 16 followed by ampli®cation of with the hGDF3-speci®c internal primer TTCTGCAGG-CAGGAGGAAGC and the 3' anchored primer TAA-TACGACTCACTATAG. 5' RACE was carried out according to the RNA ligase-mediated method (Troutt et al., 1992) . Primer GCGGCCGCCTATAGTGTCACC-TAAATC was ligated to the 3' end of ®rst strand T2cl13 EC cell cDNA, to provide a 5' anchor for subsequent ampli®cation. PCR was carried out employing the anchor-speci®c primer GATTTAGGTGACACTATAG and the hGDF3-speci®c (antisense) primer CTACATC-CAGCAGGCTAAG. PCR products were cloned using the pGEMT cloning kit as per manufacturer instructions, and sequenced using a commercial kit (Pharmacia Biotech.). Sequences were con®rmed by sequencing both strands of more than one clone.
Screening of radiation hybrid DNA by PCR hGDF3 speci®c primers hGDF3-5' (CAGCCTGAAGA-CA-CCTGTGC) and hGDF3-3' (ATTGTCCTGGTA-GAGC-ATGG) were employed in PCR reactions on genomic DNA according to standard protocols (Innis and Gelfand, 1990) . Conditions were 968C/30''; 558C/30'' and 728C/30'' for 40 cycles, with a pre-ampli®cation step of 968C/4'. PCR reactions were separated on a 2% agarose gel and evaluated for the presence of a 284 bp speci®c band.
Nucleic acid isolation and analysis
Plasmid and genomic DNA preparation and analysis was carried out according to standard protocols (Sambrook et al., 1989) . Polyadenylated (polyA) RNA was isolated from tissue culture monolayers as described (Caricasole and Ward, 1993b) and analysed by Northern blotting hybridization and RNase protection according to standad protocols (Sambrook et al., 1989) . Total RNA was isolated from primary tumour material and RNase protection experiments were carried out using 5 mg total RNA as previously described (Sambrook et al., 1989) . Genomic DNA was isolated and analysed by Southern blotting essentially as described (Sambrook et al., 1989) . All probes were synthesized by random priming employing a commercial kit (Readyprime-Amersham). The analysis of hGDF3 expression in human tissues was carried out using commercial Northern blots (Clontech Inc., Palo Alto, CA, USA).
Tissue samples and in situ hybridisation
Tumour specimens were obtained from unilateral orchidectomies suspected for the presence of a TGCT. Samples were collected and classi®ed as previously described (Oosterhuis et al., 1989) . Samples were processed for total RNA isolation exactly as detailed in Mosselman et al. (1996) . In situ analysis with hGDF3 probes were carried out as described in Baarends et al. (1995) .
